Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Clinical trial NCT03002077 · COMPLETED
Trial details
- NCT number
- NCT03002077
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-03
- Primary completion
- 2018-12-06
- Enrollment
- 617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.